Page last updated: 2024-12-09

n-octyl-beta-d-thioglucopyranoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-octyl-beta-D-thioglucopyranoside: new non-ionic detergent that is more stable than n-octyl-beta-D-glucopyranoside [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID656909
CHEBI ID194397
SCHEMBL ID151041
MeSH IDM0126707

Synonyms (32)

Synonym
85618-21-9
octyl 1-thio-beta-d-glucopyranoside
2-hydroxymethyl-6-octylsulfanyl-tetrahydro-pyran-3,4,5-triol
octyl beta-d-1-thioglucopyranoside, >=98.0% (gc)
n-octyl-beta-d-thioglucopyranoside
DB08558
octyl-beta-d-thioglucopyranoside
octyl |a-d-thioglucopyranoside
(2r,3s,5r,6s)-2-(hydroxymethyl)-6-octylsulfanyloxane-3,4,5-triol
CHEBI:194397
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-octylsulanyloxane-3,4,5-triol
octyl thioglucoside
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(octylsulfanyl)oxane-3,4,5-triol
n-octyl-beta-d-thioglucoside
AKOS017343238
SCHEMBL151041
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(octylthio)tetrahydro-2h-pyran-3,4,5-triol
octylthioglucopyranoside
mfcd00012189
octyl beta-d-1-thioglucopyranoside, >=99% (tlc)
1-s-octyl-beta-d-thioglucopyranoside
AS-61772
A863508
DTXSID50893686
octyl beta-d-1-thioglucopyranoside
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-octylsulfanyl-tetrahydropyran-3,4,5-triol
n-octyl beta-d-thioglucopyranoside
Q7073093
n-octyl- beta -d-thioglucopyranoside
b-d-glucopyranoside, octyl 1-thio-
HY-W040224
CS-W020964
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
S-glycosyl compoundA glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and a S atom bound to a carbon atom, thus creating a C-S bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
hopanoid biosynthesis (bacteria)830

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (9.09)18.7374
1990's13 (29.55)18.2507
2000's16 (36.36)29.6817
2010's7 (15.91)24.3611
2020's4 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.27 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]